These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 3907278)
1. Perphenazine decanoate vs. perphenazine enanthate: efficacy and side effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients. Knudsen P; Hansen LB; Auken G; Waehrens J; Højholdt K; Larsen NE Acta Psychiatr Scand Suppl; 1985; 322():15-28. PubMed ID: 3907278 [TBL] [Abstract][Full Text] [Related]
2. Long-term depot neuroleptic treatment with perphenazine decanoate. I. Efficacy and side effects in a 12 month study of 42 drug monitored psychotic patients. Knudsen P; Hansen LB; Højholdt K; Larsen NE Acta Psychiatr Scand Suppl; 1985; 322():29-40. PubMed ID: 3907279 [TBL] [Abstract][Full Text] [Related]
3. Long-term depot neuroleptic treatment with perphenazine decanoate. II. Different depot intervals in the last 6 months of a 12 month study of 42 drug monitored psychotic patients. Knudsen P; Hansen LB; Højholdt K; Larsen NE Acta Psychiatr Scand Suppl; 1985; 322():41-50. PubMed ID: 3934921 [TBL] [Abstract][Full Text] [Related]
4. Perphenazine decanoate in sesame oil vs. perphenazine enanthate in sesame oil: a comparative study of pharmacokinetic properties and some clinical implications. Knudsen P; Hansen LB; Larsen NE Acta Psychiatr Scand Suppl; 1985; 322():11-4. PubMed ID: 3865500 [TBL] [Abstract][Full Text] [Related]
5. [Double-blind comparison of 2 depot neuroleptics (perphenazine enanthate and flupentixol decanoate) in chronic schizophrenia (author's transl)]. Eufe R; Wegener G Nervenarzt; 1979 Aug; 50(8):534-9. PubMed ID: 394015 [No Abstract] [Full Text] [Related]
6. The relationship between blood perphenazine levels, early resolution of psychotic symptoms, and side effects. Mazure CM; Nelson JC; Jatlow PI; Kincare P; Bowers MB J Clin Psychiatry; 1990 Aug; 51(8):330-4. PubMed ID: 2199431 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression. Rothschild AJ; Samson JA; Bessette MP; Carter-Campbell JT J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930 [TBL] [Abstract][Full Text] [Related]
8. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients. Wistedt B Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648 [TBL] [Abstract][Full Text] [Related]
11. Effects and side-effects of bromperidol in comparison with other antipsychotic drugs. Woggon B Acta Psychiatr Belg; 1978; 78(1):155-72. PubMed ID: 347878 [TBL] [Abstract][Full Text] [Related]
12. [A comparative study of the longacting neuroleptics perphenazin-enanthate and fluspirilene (author's transl)]. Tegeler J; Floru L Pharmakopsychiatr Neuropsychopharmakol; 1979 Sep; 12(5):357-65. PubMed ID: 504342 [TBL] [Abstract][Full Text] [Related]
13. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
14. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial. Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193 [TBL] [Abstract][Full Text] [Related]
15. Depot perphenazine decanoate and enanthate for schizophrenia. Quraishi S; David A Cochrane Database Syst Rev; 2000; (2):CD001717. PubMed ID: 10796445 [TBL] [Abstract][Full Text] [Related]
16. A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients. Dencker SJ; Giös I; Mårtensson E; Nordén T; Nyberg G; Persson R; Roman G; Stockman O; Svärd KO Psychopharmacology (Berl); 1994 Feb; 114(1):24-30. PubMed ID: 7846204 [TBL] [Abstract][Full Text] [Related]
17. Extrapyramidal symptoms and their relationship to clinical efficacy under perphenazine treatment. A controlled prospective handwriting-test study in 22 acutely ill schizophrenic patients. Gerken A; Wetzel H; Benkert O Pharmacopsychiatry; 1991 Jul; 24(4):132-7. PubMed ID: 1754609 [TBL] [Abstract][Full Text] [Related]
18. Zuclopenthixol and perphenazine in patients with acute psychotic states. A double-blind multicentre study. Remvig J; Larsen H; Rask P; Skausig OB; Skov S; Strömgren LS Pharmacopsychiatry; 1987 Jul; 20(4):147-54. PubMed ID: 3615572 [TBL] [Abstract][Full Text] [Related]
19. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation. Chouinard G; Safadi G; Beauclair L J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017 [TBL] [Abstract][Full Text] [Related]
20. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate. Cookson JC; Kennedy NM; Gribbon D Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]